These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35720108)

  • 1. Case Report: A Novel AChR Epsilon Variant Causing a Clinically Discordant Salbutamol Responsive Congenital Myasthenic Syndrome in Two Egyptian Siblings.
    Gómez-García de la Banda M; Simental-Aldaba E; Fahmy N; Sternberg D; Blondy P; Quijano-Roy S; Malfatti E
    Front Neurol; 2022; 13():909715. PubMed ID: 35720108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Homozygous Variant in the CHRNE Gene in 2 Siblings with Congenital Myasthenic Syndrome.
    Chan C; Emery L; Maltese C; Kumar A; Aliu E; Naik S; Paul D
    Child Neurol Open; 2023; 10():2329048X231216432. PubMed ID: 38034490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Strategy for Congenital Myasthenic Syndrome with CHRNE Mutations: A Meta-Analysis of Case Reports.
    Huang K; Luo YB; Bi FF; Yang H
    Curr Neuropharmacol; 2021; 19(5):718-729. PubMed ID: 32727330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
    Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
    Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital myasthenic syndrome in Turkey: clinical and genetic features in the long-term follow-up of patients.
    Gül Mert G; Özcan N; Hergüner Ö; Altunbaşak Ş; Incecik F; Bişgin A; Ceylaner S
    Acta Neurol Belg; 2021 Apr; 121(2):529-534. PubMed ID: 31773638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK.
    Gallenmüller C; Müller-Felber W; Dusl M; Stucka R; Guergueltcheva V; Blaschek A; von der Hagen M; Huebner A; Müller JS; Lochmüller H; Abicht A
    Neuromuscul Disord; 2014 Jan; 24(1):31-5. PubMed ID: 24183479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-2 Adrenergic Receptor Agonists Enhance AChR Clustering in C2C12 Myotubes: Implications for Therapy of Myasthenic Disorders.
    Clausen L; Cossins J; Beeson D
    J Neuromuscul Dis; 2018; 5(2):231-240. PubMed ID: 29865088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel c.973G>T Mutation in the ε-subunit of the Acetylcholine Receptor Causing Congenital Myasthenic Syndrome in an Iranian Family.
    Karimzadeh P; Parvizi Omran S; Ghaedi H; Omrani MD
    Balkan J Med Genet; 2019 Jun; 22(1):95-98. PubMed ID: 31523627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcitriol ameliorates motor deficits and prolongs survival of Chrne-deficient mouse, a model for congenital myasthenic syndrome, by inducing Rspo2.
    Ohkawara B; Tomita H; Inoue T; Zhang S; Kanbara S; Koshimizu H; Miyasaka Y; Takeda JI; Nishiwaki H; Nakashima H; Ito M; Masuda A; Ishiguro N; Ogi T; Ohno T; Imagama S; Ohno K
    Neurotherapeutics; 2024 Mar; 21(2):e00318. PubMed ID: 38233267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homozygous Duplication in the
    Almatrafi AM; Alluqmani MM; Basit S
    Biomedicines; 2023 Nov; 11(11):. PubMed ID: 38001983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital myasthenic syndrome: a tale of two siblings.
    Banerjee A; Datta Kanjilal S; Biswas T; Ghoshal A; Sarkar S
    Int J Neurosci; 2024 Jun; 134(3):253-255. PubMed ID: 36018836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes.
    Rodríguez Cruz PM; Palace J; Beeson D
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29874875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn.
    Müller JS; Baumeister SK; Schara U; Cossins J; Krause S; von der Hagen M; Huebner A; Webster R; Beeson D; Lochmüller H; Abicht A
    Brain; 2006 Oct; 129(Pt 10):2784-93. PubMed ID: 16916845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Clinical Phenotypes in Congenital Myasthenic Syndrome Associated with the c.1327delG Frameshift Mutation in CHRNE Encoding the Acetylcholine Receptor Epsilon Subunit.
    Kastreva K; Chamova T; Blagoeva S; Bichev S; Mihaylova V; Meyer S; Thompson R; Cherninkova S; Guergueltcheva V; Lochmuller H; Tournev I
    J Neuromuscul Dis; 2024; 11(5):1011-1020. PubMed ID: 38995797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of β
    Rossi L; Mota BI; Valadão PAC; Magalhães-Gomes MPS; Oliveira BS; Guatimosim S; Navegantes LCC; Miranda AS; Prado MAM; Prado VF; Guatimosim C
    Neuropharmacology; 2024 Dec; 260():110116. PubMed ID: 39151654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital myasthenic syndromes: phenotypic expression and pathophysiological characterisation].
    Andreux F; Hantaï D; Eymard B
    Rev Neurol (Paris); 2004 Feb; 160(2):163-76. PubMed ID: 15034473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes.
    McMacken G; Cox D; Roos A; Müller J; Whittaker R; Lochmüller H
    Hum Mol Genet; 2018 May; 27(9):1556-1564. PubMed ID: 29462491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case report of congenital myasthenic syndrome caused by a mutation in theCHRNE genein the Iranian population.
    Farjami Z; Khodaenia N; Ebrahimi N; Zamani G; Ashnaei AH; Galehdari M; Moradyar M; Houshmand M
    Iran J Child Neurol; 2020; 14(4):87-94. PubMed ID: 33193787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Congenital myasthenic syndrome: phenotypic variability in patients harbouring p.T159P mutation in
    Ardissone A; Moroni I; Bernasconi P; Brugnoni R
    Acta Myol; 2017 Mar; 36(1):28-32. PubMed ID: 28690392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Congenital myasthenic syndromes: difficulties in the diagnosis, course and prognosis, and therapy--The French National Congenital Myasthenic Syndrome Network experience].
    Eymard B; Stojkovic T; Sternberg D; Richard P; Nicole S; Fournier E; Béhin A; Laforêt P; Servais L; Romero N; Fardeau M; Hantaï D;
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S45-55. PubMed ID: 23452772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.